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Chapter 1-Introduction 
            
            The term ‘Periodontium,’ describes the tissues supporting and investing the tooth. It is 
comprised of the periodontal ligament (PDL), root cementum, alveolar bone and that part of 
the  gingiva facing the tooth (Nanci et al., 2006). Each of the periodontal components has its 
very specialized structure and these structural characteristics directly define function.  The 
periodontium protects, supports, and provides nourishment to the tooth. The PDL is a 
connective tissue embedded between the cementum and the inner wall of the alveolar bone 
socket. It is composed mainly of collagen fibers, ground substance and cells. The cells include 
fibroblasts, osteoblasts, osteoclasts, epithelial rest cells of Malassez, macrophages, 
undifferentiated mesenchymal cells, axons with Schwann cells, endothelial cells and 
cementoblasts (Marchesan et al., 2011). They all contribute to the development, repair and 
regeneration of the PDL and the surrounding structures.  The main mechanical function of the 
PDL is to provide an elastic resistance to the matiscative forces. It also plays an important role 
in the regeneration of cementum, bone, as well as maintaining itself. Proper functioning of the 
periodontium is only achieved through structural integrity and interaction between its 
components. Disease and/or injury to the periodontium can result from microbial insult as well 
as affected by other factors including, systemic disease, aging, trauma, genetics, and iatrogenic 
activity (Nanci et al., 2006). Achieving periodontal regeneration is difficult, requiring several 
tissues to be reconstructed. One of the early steps in this process is the attachment of new 
connective tissue fibers to the root surface. The cementum covering the root has an important 
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role in this process as it invests and securely attaches the PDL fibers to the root surface and 
therefore, cementogenesis is a critical process for homeostasis and regeneration of the 
periodontium (Bosshardt et al., 1996). 
            The complex processes that regulate cementogenesis and normal cementum 
metabolism remain unclear to date. Recent evidence indicates that cementum formation is 
critical for appropriate maturation of the periodontium (Villarreal-Ramirez et al., 2009). 
Although cementum was first described in 1835 and its recognition probably dates back to 1667 
(Zander et al., 1958), only until recently has it remained a poorly defined tissue at the cellular 
and molecular level. Classification of cementum via light and electron microscopy has defined 
several subtypes based on the presence (cellular) or absence (acellular) of cells and the source 
of collagen fibers (extrinsic vs intrinsic). Acellular extrinsic fiber or primary cementum is found 
on the cervical half to two thirds of the root, whereas cellular intrinsic fiber or secondary 
cementum is distributed along the apical third of the root and considered less well mineralized 
than acellular extrinsic fiber cementum.  All of these subtypes are quite different from bone, in 
that they lack a direct blood supply, lymph drainage, and innervation as well as exhibit little to 
no remodeling (Saygin et al., 2000). Despite these differences, cementum is still very similar to 
bone. Unlike dentin and enamel in which there are clear differences in the proteins present in 
these tissues as well as factors present regulating their function compared with bone, 
cementum on the other hand appears to contain factors in common with bone. The 
composition of cementum is approximately 50% hydroxyapatite (mineral) as well as 50% 
collagenous (organic) and noncollagenous proteins. Cementum matrix contains collagen types I 
and III and possesses proteins similar to bone. More specifically, these include bone 
[7] 
 
sialoprotein, osteopontin, vitronectin, fibronectin, osteocalcin, osteonectin, proteoglycans and 
growth factors such as transforming growth factor (TGF-β) and bone morphogenetic protein-3 
(BMP-3) (Saygin et al., 2000). Osteopontin (OPN) and bone sialoprotein (BSP) have been 
implicated in mineral deposition as well as cell- and matrix-matrix interactions. OPN has a poly-
Asp and BSP two poly-Glu domains, whose repetitive sequences are known to bind calcium to 
mineral surfaces. OPN is a molecule associated with early stages of mineralization and its 
expression by cementum tumor cells suggests that this molecule could be associated with the 
initial process of mineralization observed in cementum tumor cells (Arzate et al., 1998).  
            Research through the years has demonstrated that cementum is a unique tissue 
histologically however definitive identification of proteins specific to cementum, have not been 
revealed. Although they seem to function similarly in both bone and cementum one challenge 
presented in studying cementoblastic differentiation is due in part from the inability to identify 
fully differentiated cementoblasts because most molecules expressed by cementoblasts are 
pleiotropic and only few cementum-specific markers having been described (Paula-Silva et al., 
2010). An adhesion molecule, cementum-derived attachment protein (CAP), and a growth 
factor, cementum protein (CP), are present in the mature cementum. CAP is characterized as a 
collagen-like protein with a molecular weight of 56 kDa and restricted to cementum and 
periodontally-derived cells, and although CAP and osteopontin are generally considered to be 
different proteins, it is not possible to rule out the possibility that CAP may be a variant of 
osteopontin formed by differential splicing of its mRNA (Arzate et al., 1992; Wu et al., 1996). 
CAP and CP appear to be immunologically related to each other and an extensive investigation 
revealing the expression of a novel cDNA obtained from a human cementoblastic-derived cell 
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line isolated a tissue-specific-gene product, CP-23, which was expressed by periodontal 
ligament cell subpopulations and cementoblasts (Alvarez-Perez et al., 2006). With the lack of 
specific cementum markers and an inherent difficulty obtaining a pure cell population, viable 
cementoblasts have not yet been isolated. Attempts have been made to isolate cells that 
express the cementoblast phenotype (Arzate et al., 1992). Arzate et al (1992) proposed 
culturing cementum tumor cells for at least three reasons: first, they could be used to obtain 
sufficient quantities of biologically active cementum components due to the paucity of 
cementum in human teeth and intensive dissection procedures necessary; second, the cells can 
be used to study the biosynthesis and processing of CAP and other cementum proteins; and 
third, early cementogenesis is believed to involve deposition of extracellular matrix produced 
by Hertwig’s epithelial root sheath (HERS) cells on dentin, as well as disruption of the HERS, 
migration and attachment of ectomesenchymal cells from dental follicle onto the matrix, their 
differentiation into cementoblasts, and laying down of cementum. The Arzate group in 2000, 
isolated and characterized a human cementoblastoma-derived cell line that expressed the 
cementum phenotype and went further to reveal via energy dispersive X-ray microanalysis 
(EDX) in a time course fashion, that the extracellular matrix material deposited had similar Ca/P 
ratios for both cementoblastoma-derived and osteoblastic cells of 1.6 and 1.628 respectively 
(1.97 for human cementum). These values were similar to those reported for hydroxyapatite in 
enamel and bone. Strong immunostaining for CAP in cementum tumor-derived cells indicated 
this was a significant source for this protein yet, several osteoblastic cells also immunoreacted, 
which implies cementoblasts and osteoblasts share a common ancestor (Arzate et al., 1998; 
Arzate et al., 2000). Arzate’ s group via immunolocalization, showed CP was expressed 
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specifically in precementum as well as cells paravascular to the blood vessels in the rest of the 
PDL, but cells in the PDL were only lightly stained; therefore, CP is periodontal ligament and 
cementum-specific. This protein was termed “cementum protein-23” (CP-23). The group 
revealed 98% of putative cementoblasts and 15% of periodontal ligament cells cultured in vitro 
expressed the CP-23 gene product (Alvarez-Perez et al., 2006).  
            Subsequently, Arzate and his group (Arzate et al., 2007) demonstrated that transfection 
of a human cementoblastoma-derived protein named Cementum Protein 1 (CEMP1) into 
human gingival fibroblasts induced mineralization and expression of bone and cementum-
matrix proteins. This protein like CP-23 was expressed by cementoblasts and progenitor cells 
localized in the periodontal ligament. The transfected human gingival fibroblasts had higher 
alkaline phosphatase activity and expressed genes for bone sialoprotein, osteocalcin, 
osteopontin and also produced biological-type hydroxyapatite (Carmona-Rodriguez et al., 
2007). The findings of this study indicated that CEMP1 may participate not only in 
differentiation and mineralization of nonosteogenic cells, but function in cementum and bone 
formation as well. Since CEMP1 is synthesized by cementoblast cells and a restricted 
periodontal ligament cell subpopulation (cementoblast precursors), it has been suggested that 
this protein is a cementum-specific biological marker. Utilizing this theory, Arzate’s group in 
2009 produced a full length human recombinant CEMP1 protein in human gingival fibroblasts 
(Arzate et al., 2009). The identity of the human recombinant protein was determined by 
Western blot analysis using two specific polyclonal antibodies and a single protein species of 50 
kDa was recognized; almost twice the theoretical molecular mass calculated from the cDNA 
sequence of 25.9 kDa (Villarreal-Ramirez et al., 2009).   
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            The human body has the remarkable capacity for regeneration. The unique cells that give 
rise to specialized tissues are termed stem cells. These extraordinary cells have the capacity for 
self-renewal and have the ability to give rise to one or more different cell types. In mature 
tissue, adult stem cells play a major role in homeostasis and tissue repair while even more 
remarkable, is the developmental capacity of embryonic stem cells. These cells can, in theory, 
give rise to all tissue types and are often referred to as pluripotent cells. Due to regulatory and 
ethical issues associated with the use of embryonic stem cells, attention has been redirected to 
stem cells derived from adult tissues. The regenerative potential of adult stem cells has been 
recognized for several decades. Adult stem cells can be categorized into Hematopoietic and 
Mesenchymal stem cells depending on their origin. Hematopoietic stem cell literature has been 
well established however, within the diverse population of bone marrow stromal cells, there 
exists a subset of stem cells called mesenchymal stem cells capable of self-renewal and they 
can differentiate into several phenotypes including bone, cartilage, adipocytes and 
hematopoiesis-supporting stroma (Krebsbach and Robey, 2002). Since the discovery of 
residential stem cells in the periodontal ligament, recent studies have focused on the potential 
role of these cells in cementum formation, which is essential for periodontal regeneration. 
Periodontal ligament cells have the potential to differentiate into cementoblasts (Seo et al., 
2004; Fuji et al., 2008). The cementogenic potential of these cells to form cementum/bone-like 
structure has been evaluated by in vivo transplantation assays using immunocompromised 
rodents (Seo et al., 2004, Gay et al., 2007). In addition, polymerase chain reaction (PCR) analysis 
and mineralization assays are widely used for in vitro evaluation of cementogenesis (Gay et al., 
2007; Flores et al., 2008). In light of this, a previous study isolated so called multipotent 
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postnatal stem cells from the periodontal ligament using one of the early mesenchymal stem 
cell surface markers STRO-1. These stem cells were designated PDLSCs and the results of this 
work revealed that most colony-forming cells were contained within the STRO-1 positive cell 
population, confirming STRO-1 as an early progenitor marker for PDLSCs (Seo et al., 2004). Xu et 
al went on to quantify the percentage of PDLSCs in the adult human periodontal ligament using 
cultured periodontal ligament cells from freshly extracted teeth. Magnetic bead sorting and 
flow cytometric data revealed that on average, 2.6% of periodontal ligament cells present were 
positive for the stem cells surface markers STRO-1 and CD146. This small population of cells was 
capable of multilineage differentiation toward a chondrogenic, adipogenic and osteoblastic 
phenotype thereby verifying the multipotent nature of these cells (Xu et al., 2009).  
            Paula-Silva and colleagues (2010) were the first to link STRO-1 and CEMP1 markers to 
cementogenesis. Prior to their work, molecules responsible for recruiting mesenchymal cells 
and inducing their differentiation into cementoblasts had not been identified. The results of 
their work provided evidence that CEMP1 could be one of those molecules that performs these 
functions. The group’s in vivo experiment involving exposed root canals in dogs showed that 
calcium hydroxide promoted cementogenesis and induced cementoblastic differentiation of 
mesenchymal periodontal ligament cells in a CEMP1 and ERK-dependent manner. These data 
suggest that clinical treatment with calcium hydroxide recruits mesenchymal STRO-1 positive 
PDL cells via a CEMP1 gradient that in turn, promotes mesenchymal cell differentiation toward 
cementogenesis. They further showed that in vivo calcium hydroxide treatment formed 
neocementum at the dental root apex of these repaired teeth in a STRO-1 positive and CEMP1 
positive cellular environment. Due to the proximity of the staining of these two markers, they 
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proposed that cells positive for STRO-1 may also be positive for CEMP1 (Paula-Silva et al., 2010). 
This concept was expanded upon recently (Aminlari et al., 2011, unpublished) as STRO-1 
positive PDL cells that are also CEMP1 positive, were shown to have properties consistent with 
cementoblasts and can be directed toward cementogenesis. This group revealed the presence 
of STRO-1 and CEMP1 markers on postnatal stem cells from the PDL and went further through 
magnetic bead sorting, flow cytometric analysis, immunofluorescence analyses, dilution 
cloning, mRNA isolation, and mineralized tissue analysis to test whether STRO-1/CEMP1 double 
positive clones can be both successfully differentiated into cementoblast-like cells and produce 
cementum-like tissue. The results of their study showed successful cloning of STRO-1/CEMP1 
positive cells able to produce mineralized-like tissue with features similar to those of 
cementum; more specifically, a Ca/P ratio of 1.89 which as mentioned previously, is very close 
to human cementum at 1.97 (Arzate, et al., 2000). Despite these findings however, mRNA 
expression levels of CEMP1 were highest in the osteogenically induced parental PDL cells, not 
necessarily in the STRO-1 positive cells (which were CEMP1 positive as well) as anticipated. The 
authors predicted that the STRO-1 positive cells (which were CEMP1 positive as well) would 
express the highest levels of CEMP1, and hypothesized that they did not due in part, to the 
inherent “young age” and early passage of the parental PDL cells as opposed to the serially 
diluted and late passage (“old age”) of the STRO-1/CEMP1 positive cells. Perhaps CEMP1 
expression in fact occurs much earlier than the 14-day time course assay performed. The 
temporal expression and regulation of CEMP1 expression during differentiation toward 
mineralization is not known. Therefore, additional time point assays were performed on 
osteogenically induced parental PDL cells and magnetic bead isolated STRO-1 positive cells 
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whereby CEMP1 expression was examined at 3 and 7 days and it was found that CEMP1 
expression was very low at both 3 and 7 days. The authors suggested that perhaps earlier and 
later time points would best serve to examine the optimal time to assay for CEMP1 expression 
during differentiation processes. (Aminlari 2011, unpublished). 
 
Cellular Senescence and Cementum Markers  
            In addition to identifying optimal time points to assay for high expression of CEMP1, the 
concept of cellular senescence became important since cell experiments often required 
multiple cell passages. Senescence or biological aging is defined as the endogenous and 
hereditary process of accumulative changes to molecular and cellular structure disrupting 
metabolism and resulting in death. Senescence occurs at both the level of the entire organism 
as well as at the level of its individual cells (Hayflick 1977). Once cells have entered senescence, 
they cease to divide and undergo a series of dramatic morphologic and metabolic changes. 
Aged cells accumulate age-related damage and become post-mitotic when they can no longer 
replicate. They also can no longer express the full gamut of markers they once could at an 
earlier age or passage. Viewed historically as a cell-intrinsic mechanism, senescence functions 
to restrict unlimited cell proliferation. This concept originated from classic experiments 
performed by Leonard Hayflick in the early 1960’s, who found normal human fibroblasts cease 
to divide following a period of proliferation in culture (Hayflick et al., 1961). However, the 
physiologic role of senescence remains poorly understood (Ben-Porath, Weinberg, ’05). It is 
quite possible for serially diluted cells or cells undergoing multiple passages to become ‘tired’ 
and unable to express certain markers.  Another reason is that cells develop multiple mutations 
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over time, and in order to ‘weed-out’ potentially cancerous-like cells, the cells will no longer 
continue to divide and pass on these mutations. These cells undergo senescence and stop 
dividing. Most recently, Komaki et al investigated the change in CEMP1 expression during the 
differentiation of human periodontal ligament cells. Their objective was to investigate if CEMP1 
is a regulator of cementoblasts. Immunocytochemical analyses and RT-qPCR revealed CEMP1 
expression was reduced when periodontal ligament cells differentiated into osteoblasts in vitro; 
more specifically, they found that CEMP1 expression was reduced when periodontal ligament 
cells were cultured under osteogenic conditions, i.e., cultured with osteogenic induction 
medium. The results went on to reveal CEMP1 expression declines when cells are committed to 
osteo-/chondro-blastic lineages in an in vivo diffusion chamber assay, which suggests that 
CEMP1 expression may be differentially regulated in osteoblasts and cementoblasts (Komaki et 
al., 2012). 
            It is believed the degree of periodontal tissue breakdown and tooth loss increase with 
age. The most important elements of the periodontal ligament are the principal fibers, which 
are collagenous, arranged in bundles, and the terminal portions insert into cementum and 
alveolar bone. Therefore the periodontal ligament not only has a primary function of tooth 
support, but also an important function in the tissue regeneration of the periodontal ligament 
itself, alveolar bone and cementum (Nanci et al., 2006). While some studies describing the 
changes of the periodontal ligament with age have been reported, they were limited to 
histological investigations. Therefore clarifying biological changes of the periodontal ligament 
with the process of aging would be useful to elucidate a relationship (if any) between 
periodontal breakdown and age. This may prove useful in maintaining periodontal health over a 
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lifetime (Goseki et al., 1996). Healthy periodontal ligament from old subjects for biochemical 
assay however, is difficult to obtain because healthy teeth are rarely removed from the aged. 
 
Hypothesis and Specific Aims 
            Reports from the literature conveying the notion that human fibroblast cultures derived 
from a variety of tissues types have a limited proliferative life-span thereby defining the 
measurable parameter of a finite number of population doublings in tissue culture and has 
been termed ‘cellular aging’ (Hayflick et al., 1961; Hayflick, 1977); therefore the life-span of 
certain cultured cells including human fibroblasts, indeed has a correlation with that of each 
species and the concept of a direct relationship between cellular life span and species longevity 
is supported (Rohme, 1981).  As mentioned earlier, Paula-Silva et al showed that calcium 
hydroxide promotes cementogenesis and induces cementoblastic differentiation of 
mesenchymal PDL cells in a CEMP1 and ERK-dependent manner. They proposed that CEMP1 
might be a mediator in periodontal regeneration as it stimulates PDL cell proliferation and 
migration. However, to date, no one has examined CEMP1 expression in the periodontal 
ligament cell with relation to cell aging. Specifically it is not known whether: 1) STRO-1 positive 
PDL cells that are also CEMP1 positive, express CEMP1 after the cell has aged 2) STRO-1 positive 
PDL cells that are also CEMP1 positive, can be driven toward a cementogenic phenotype after 
the cell has aged and 3) there is a specific time point at which CEMP1 expression is highest 
during differentiation to a cementoblast. In these studies we therefore tested the hypothesis 
that STRO-1 positive PDL cells that are also CEMP1 positive will have variable expression of 
cementum protein-one as the cell ages with potential peak expression at a younger age.  
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            To test our hypothesis, we used human PDL cells obtained from the teeth of 12-16 year-
old patients and investigated the effects of in vitro cellular aging on cementum protein 1 
(CEMP1), Collagen 1 (Col 1), and Osteopontin (OPN) all of which may play important roles in 
periodontal tissue function. To confirm that STRO-1 and CEMP1 markers are present on 
postnatal stem cells from the PDL, and that these markers can be used to successfully isolate 
PDL cells from freshly extracted teeth for further differentiation to cementoblasts, we used 
magnetic bead sorting, immunofluorescence analyses, Western blotting and a baseline RT-qPCR 
to detect and quantify these markers. To test whether STRO-1/CEMP1 double positive PDL cells 
could be differentiated into cementoblast-like cells after they age, we differentiated these aged 
cells as well as aged parental PDL, double negative control counterparts, cementoblastoma 
controls, and human mesenchymal stem cells in a time course fashion toward a mineralization 
phenotype. Evaluation of cementoblast-like characteristics was assessed via mRNA 
expression/RT-qPCR for CEMP1, Col 1 and OPN. Confirmation of STRO-1/CEMP1 double positive 
and double negative controls was performed using both immunocytochemistry and Western 
blotting. Mineral production and quantification was confirmed using Alizarin Red S staining. 
Student’s t-test was performed for statistical analysis when indicated. We expect to see a 
decrease or downregulation in CEMP1, Collagen 1 and Osteopontin expression with cellular 
aging.  
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Chapter 2- Methods and Materials 
 
 
 
 
 
Flow chart of experimental design and assays performed 
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PDL Cell Isolation  
            Freshly extracted maxillary and mandibular premolars from human subjects ages 12-16 
were obtained from the Oral Surgery Department under informed consent at the University of 
Michigan, School of Dentistry. Teeth were quickly placed in media containing α-minimal 
essential media (α-MEM) with L-Glutamine and without Ribonucleosides or 
Deoxyribonucleotides. Under sterile conditions, the teeth were washed twice with PBS. The PDL 
tissues from the middle third of the roots were scraped using a sterile blade as previously 
described (Xu, Wang et al. '09). The tissues were minced and covered with sterile glass 
coverslips, held down by Vaseline at three points, in 35mm tissue culture dishes in α-MEM 
supplemented with 10% fetal bovine serum (FBS), 1% penicillin–streptomycin, and Fungizone 
(Invitrogen Corp., Carlsbad, CA, USA). The plates were labeled ART PDL-1, ART PDL-2, and so on. 
The plates were incubated in a humidified atmosphere (37°C, 5% CO2), and the media was 
replaced every two to three days for up to a month. PDL cells that grew out of the PDL tissue 
were passaged into 10-cm plates by first washing with 5mL PBS, then incubating with 1 mL of 
0.05% Trypsin-EDTA for 5 minutes until the cells detached from the plate and were floating in 
the media. Finally the Trypsin was inactivated with 5 mL of α-MEM medium containing the 1% 
FBS and 1% P/S (Hereinafter “PDL Growth Media”). The cells were centrifuged at 1000 rpm for 
5 min, the supernatant removed and the cells resuspended in new PDL Growth Media and 
plated. Once confluent, they were again passaged. Passage 2 and 3 cells were used for cell 
isolation and subsequent experiments. Human cementoblastoma (TCN) cells were kindly 
provided by Dr. Higinio Arzate (UNAM, Mexico City, Mexico) and were cultured in αMEM with 
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10% fetal bovine serum plus 1% penicillin/streptomycin. Human mesenchymal stem cells 
(hMSCs) purchased from Lonza (Lonza, MD, USA), were kindly provided by Jin Ping Xu from the 
University of Michigan and cultured in mesenchymal stem cell media. Both TCN and hMSC cell 
strains were prepared to passage 2 and 3 and then used for subsequent experiments. 
 
Magnetic Bead Isolation 
            In order to isolate STRO-1 positive cells for experimentation, the CELLectin Biotin Binder 
Kit (Life Technologies, Grand Island, NY) was utilized. Fresh buffers were made and adjusted to 
pH of 7.0-7.4. Passage 3 PDL cells were washed twice with 5 mL of PBS. Cells were then 
incubated with 5mL of Cell Dissociation buffer at 37°C, 5% CO2 for up to 15 min. Once the cells 
detached from the plate, 10 mL of the PDL Growth Media was added and centrifuged at 1000 
rpm for 5 min. The pellet was then resuspended in 400 μL of Buffer 2 (PBS, 1% BSA, 0.6% Na 
Citrate). The cells were incubated on ice for 60min in the presence of Mouse Anti-human STRO-
1 IgM antibody at 1:20 dilution. 
 While the cells were incubating, 25 μL of the magnetic Dynabeads were transferred to a 
new test tube and washed twice with Buffer 1 (PBS, 1% BSA) by placing in the Dynal MPC-1 
Magnetic Particle Concentrator for 1 min. The Dynabeads were then resuspended in 25 μL of 
Buffer 1 and incubated in the presence of 20 μg of Biotin conjugated Goat anti-mouse IgG for 
30 min at room temperature with occasional agitation.  
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 The cells were washed twice with Buffer 2 by centrifugation at 1000 rpm for 5 min. They 
were resuspended in 1 mL of Buffer 1. The Dynabeads were washed three times as above and 
resuspended in the initial 25 μL of Buffer 1. The cells and the Dynabeads were mixed together 
and incubated for 20 min at 4°C with gentle mixing. The mixture was placed in the magnet for 2 
min and the bead-unbound cells and supernatant removed (these were saved as “Sup” cells). 
The cell-bead complex was washed twice in Buffer 2 and resuspended in 200 μL of pre-warmed 
Buffer 3 (RPMI 1640, 1% FBS, 1% CaCl2, 1% MgCl2). Finally 6 μL of DNAse Releasing Buffer was 
added to the mixture and allowed to incubate for 15 min at room temperature. This step would 
help release the cells from the Dynabeads. The test tube was placed in the magnet again and 
the unbound cells were removed after 2 minutes. These cells would theoretically be the STRO-1 
positive cells. The last step was repeated two more times along with pipetting up and down 
using a 200-μL pipetter to fully unbind the cells. All other cells were also grown; DNAsed STRO-
1+ cells (STRO-1), Bead-bound cells (Beads), Pre-DNAse cells in the supernatant (Sup), and 
parental PDL cells. 
 
Immunofluorescence 
           STRO-1 negative, STRO-1/CEMP1 positive, parental PDL, and cementoblastoma (TCN) 
cells were subjected to staining for STRO-1 and CEMP1. Cells at passage 3-4 and passage 11-12 
were washed with 5 mL PBS and released from plates using 3 mL of Trypsin for 5 minutes at 
37°C. Cells were counted and plated in a 48 well plate at 5000 cells/well. The cells were allowed 
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to attach to the plate over night at 37°C. The next day, the cells were washed twice with 200 μL 
of PBS. To fix the cells, they were incubated in 200 μL of 4% paraformaldehyde for 15 minutes 
at room temperature. The wells were washed twice with 200 μL PBS and then blocked with 200 
μL 5% BSA in PBS with 0.3% Triton X-100 for 1 hr at room temperature. This was to prevent the 
nonspecific binding of the primary antibody. The Triton X-100 allowed the permeability of the 
cells. The wells were washed twice with PBS and 200 μL of the primary antibody buffer (PBS, 
0.3% Triton X-100, 1:200 dilution of Mouse anti-human STRO-1 monoclonal IgM antibody (BioFx 
Labs, MD), and 1:300 dilution of hCEMP1 antibody (Kindly provided by Dr. H Arzate, UNAM, 
Mexico City, Mexico) was added. Negative controls were incubated with either no antibody or 
Normal mouse IgG at 1:150 dilutions. The plates were wrapped in paraffin to prevent 
evaporation and incubated overnight in 4°C. 
 On the third day, the wells were washed twice with 200 μL PBS and incubated for 2 
hours in the dark with the secondary antibody buffer (PBS, 0.3% Triton X-100, 1:300 dilution 
FITC conjugated Goat anti-Mouse IgM antibody, 1:300 dilution Texas Red conjugated donkey 
anti-Rat IgG antibody). The wells were washed twice with PBS. To stain the nuclei, DAPI staining 
was used by incubating the cells in 200 μL of 1:5000 dilution of DAPI in PBS for 1 minute. The 
cells were washed again and finally observed under the light microscope with the appropriate 
filters for FITC, Texas Red, and DAPI. Pictures were taken using the Q-Capture Pro software and 
Evolution MP digital camera attached to a Nikon TS 100 microscope.  
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Cellular Aging of PDL, STRO-1 positive, STRO-1 negative, TCN and hMSC cells 
             All cell strains were cultured in α-MEM, hMSC medium, or osteogenic medium as 
previously described, on 10cm plates and allowed to reach 90% confluency (~2.5x106 cells). 
Cellular aging was performed by subcultivation according to Goseki and Hayflick (Goseki et al., 
1996), (Hayflick, 1977). Briefly, cells were incubated on 10cm plates as either: PDL isolated, 
STRO-1 positive or STRO-1 negative bead isolated, hMSC or TCN donated cells at 5% CO2 and 
37° C while changing the medium every 3 days. Once cellular confluence was achieved, cells 
were passaged with 0.05% Trypsin as previously described. Cells plated as P2 or P3 were either 
used immediately or passaged again to appropriate plates (6cm or 6 well) for specific assays 
and considered ‘young’ cells (P 3-4) for each experiment thereafter. When cells had reached 
confluence at around one-week intervals, they were subcultivated in a 4:1 split ratio so that 
two population doublings per subcultivation would result. After the 10th to 11th passage, the 
growth rate of the cells decreased (certain cell strains more markedly than others), thereby 
increasing the time required to reach confluence (up to two weeks for hMSC and TCN cells). 
The resulting cells were then split into a ratio of 2:1 if necessary in order to achieve passage 12 
or more, and at this late passage the cells were considered ‘aged’ (P 11-13).  
 
Osteogenic/Cementogenic differentiation 
            All cell strains young and aged, were osteogenically induced in either a time course 
fashion for mRNA analysis or for Alizarin Red S staining. Young and aged Parental PDL cells, 
supernatant or STRO-1 negative cells, STRO-1/CEMP1 positive cells, human mesenchymal stem 
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cells, and cementoblastoma cells (TCN cells) were washed and detached using 0.05% trypsin for 
5 min and the trypsin deactivated with MSC growth media. The cells were counted, centrifuged, 
and resuspended in an appropriate type and amount of MSC growth media. A total of 5X105 
cells were transferred to each 6cm plate or 3x104 cells were transferred to each well of a 6-well 
plate. 90 total 6cm plates and 8 total 6-well plates were seeded as seen in figure 13 and figures 
17 - 18 respectively. Each 6-well plate was a single cell strain performed in triplicate for Alizarin 
Red staining using osteogenic medium and control medium. RNA analysis involved nine 6cm 
plates for each cell strain in a time course fashion (0hr, 6hr, 24hr, 72hr and 1wk) for both young 
and aged cells also using osteogenic medium and control medium. 3 wells of each 6-well plate 
were osteogenically induced, and the other 3 wells served as controls. Forty 6cm plates were 
also osteogenically induced and fifty 6cm plates then served as controls after which, RNA 
isolation would be performed at each specific time point for treated and untreated cells (0hr, 
6hr, 24hr, 72hr, and 1wk). To induce differentiation, the control media was replaced with the 
osteogenic induction media containing L-glutamine, ascorbate, dexamethasone, and -
glycerophosphate according to the manufacturer’s instructions (Lonza, MD USA). The media 
was replaced every 3-4 days. At the end of one week, the 6cm plates were designated for RNA 
extraction, reverse transcription and subsequent RT-qPCR and at the end of two weeks, the 6 
well plates were designated for Alizarin Red S staining. 
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Alizarin Red S Staining 
            Upon the completion of the osteogenic induction at two weeks, eight 6-well plates 
were stained for mineral content using the Alizarin Red S staining protocol.  The solution was 
freshly made adding 0.5 mg of Alizarin red dye to 100 mL sterile deionized water (dH2O) and 
mixed well. The media was discarded from each well and the cells washed two times with PBS. 
The cells were then fixed with 2 mL of 70% ethanol for 10 min. The ethanol was then removed 
and wells allowed to air dry. The cells were then stained with 2 mL of the Alizarin red dye 
solution for 5 min.  Finally, they were washed two times with sterile dH2O; air dried, and 
scanned using an Epson double-sided radiograph-scanning machine and Apple Mac computer. 
 To quantify the amount of Alizarin Red S staining, the plates were incubated for 30 min 
in 1 mL of 100 mM cetylpyridinium chloride. At this point, 200 L of the now blue solution was 
placed in triplicate in a 96-well plate and read using a spectrophotometer at an OD reading of 
570nm. Student’s t-test was used for analysis of the results comparing aged vs young cells. P < 
0.05 was considered significant. 
  
RNA Extraction 
            Upon completion of young and aged cell culture for both baseline, and time course 
evaluation with osteogenic induction at the end of one week, forty (40) osteogenic 6cm plates 
and seventy four (74) control 6cm plates were dedicated to RNA isolation and qRT-PCR. RNA 
extraction was performed using the RNeasy Mini Kit (Qiagen, USA). The cells were washed 
twice with cold PBS. The cells were then coated with 350 L of RLT lyses buffer with ethanol for 
[25] 
 
10 min at room temperature before they were scraped and pipetted into a Q1A-Shredder mini-
spin column and centrifuged at 13,000 rpm for 2 min. Subsequently, 350-500 L of fresh 
biologic grade 70% ethanol was added and mixed by pipetting. This mixture was placed in a 
mini column with a collecting tube and centrifuged for 15 sec at 13,000 rpm. At this point, the 
RNA theoretically stayed in the spin column. The eluent was discarded. The column was then 
washed once with 350 L of Washing Buffer RWL. At this time, the DNase step was performed 
with the DNase Kit (Qiagen, USA) by adding 10 L of DNase stock solution to 70 L of Buffer 
RDD. Once gently mixed, add the DNase incubation mix (80 L) was added directly to the 
RNeasy spin column membrane, and placed on the bench top (20-30° C) for 15 minutes. Then 
350 L of Washing Buffer RWL was added and the sample centrifuged for 15 sec at 13,000 rpm. 
Then the sample was washed with 500 L of Washing Buffer RPE twice, and centrifuged at 
13,000 rpm for 15 sec. At this time, the collecting tube was changed to a new one and the 
column spun for 2 min at 13,000 rpm. Finally, the column was transferred to a new eppendorf 
tube and 35 L of RNase-free water, provided with the kit was added to the column and 
centrifuged at 13,000 rpm for 1 min. The RNA at this point had dissolved in the water and 
transferred to the eppendorf tube. To measure the purity of the RNA, 1:25 dilution was made 
using 4 L of RNA and 96 L of RNase-free water, placed in a 6 cuvette compartment, and the 
absorbance at a ratio of 260/280 was measured using a DU-640 Spectrophotometer (Table 1 
and 2). A total of 98 samples (baseline and time course young/aged) were stored in the - 80C 
freezer until further processing. 
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Reverse Transcription 
            In order to perform RT-qPCR, the RNA samples required reverse transcription (RT) to 
produce complementary DNA (cDNA). Calculations were performed to allow for reverse 
transcription reactions to be performed for the time course experiment involving 45 samples of 
‘young cell’ RNA and 45 samples of ‘aged cell’ RNA as well as 8 samples of “young-, aged cell”  
RNA for the baseline experiment. A 40 µl RT reaction with 0.5µg total RNA and random 
hexamers was performed using High Capacity cDNA Reverse Transcription Kit (Life 
Technologies, Carlsbad, CA USA).  This kit included all the necessary components for the 
transcription and was utilized after removing from the -20C freezer and slowly thawed on ice.  
The thermal condition for RT was: 25°C 10 min, 37°C 120 min and 85°C 5 min and kept at 4C 
until the samples were removed from the machine. Within 24 hours or sooner, the samples 
were stored in the -20C freezer. 
 
Quantitative Real-Time Polymerase Chain Reaction 
            Real time polymerase chain reaction (qPCR) was performed in quadruplicate on the 
cDNA samples from each of the five cell strains in each time course group compiling ninety 
samples total and each of the four cell types in the baseline group compiling eight samples 
total. The reaction was performed by using TaqMan® Universal PCR Master Mix (Life 
Technologies, Carlsbad, CA) and Vii7 Applied Biosystems PCR system (Applied Biosystems, 
Foster City, CA). Briefly, a 30 µl PCR reaction was prepared with 1µl cDNA (RT product) and 
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1.5µl gene specific probe and primers mixture from Life Technologies TaqMan® Gene 
Expression Assays. The sequences for the probes are listed in Table 3.  The real-time PCR 
thermal condition was: 50°C 2 min, 95°C 10 min followed by 40 cycles of 95°C 15 sec and 60°C 
1 min. Relative quantification was performed using the ∆∆Ct method (Livak '01), data were 
normalized to the expression of GAPDH and Student’s t-test was applied to compare 
statistically significant differences between groups (young vs aged cells). P values < 0.05 were 
considered significant. 
  
Baseline Messenger RNA Expression 
            Baseline expression of CEMP1, osteopontin, and collagen 1 in ‘young’ and ‘aged’ parental 
PDL cells, STRO-1/CEMP1 positive cells, STRO-1 negative cells, and cementoblastoma (TCN) 
cells, was evaluated and normalized to the housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) using RT-qPCR with TaqMan primer/probes. The relative mRNA 
expression from this baseline experiment was then compared with the relative mRNA 
expression of the same genes in the same ‘young and ‘aged’ cells osteogenically induced in a 
time course fashion with the addition of human mesenchymal stem cells (hMSCs) in the time 
course experiment. 
 
Time Course Messenger RNA Expression 
            Expression of CEMP1, osteopontin, and collagen I in ‘young’ and ‘aged’ parental PDL 
cells, STRO-1/CEMP1 positive cells, STRO-1 negative cells, cementoblastoma (TCN) cells, and 
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human mesenchymal stem cells (hMSCs) was evaluated and normalized to the housekeeping 
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in a time course fashion using RT-
qPCR with TaqMan primer/probes. Briefly, cells were plated young and aged as previously 
described on nine 6cm plates to ~70-80% confluency (1x106 cells). The first plate was 
designated ‘zero hour’ (0hr) and remained untreated through the one week time frame. Two 
subsequent plates were then used for each time point thereafter at six hours (6h), twenty four 
hours (24h), seventy two hours (72h), and one week (1wk), remaining either untreated as a 
control or treated with osteogenic induction media ‘UT’ or ‘Tx’ (Fig 13).  
      
Western blot 
            For further confirmation of the CEMP1 marker on a protein level, western blot analysis 
was performed on parental PDL, STRO-1 positive, STRO-1 negative and cementoblastoma cells. 
Samples were cultivated on 10cm plates to ~90% confluency (2-2.5x106 cells). Plates were 
scraped, cells were detached and medium pipetted into 15mL tubes, then centrifuged at 
1000rpm for 5min at room temperature. The medium was then aspirated and the pellet 
resuspended in 500μL PBS, transferred to a 1.5mL eppendorf tube, and centrifuged @ 1000rpm 
for 5min at room temperature. The PBS was then aspirated and remaining pellet resuspended 
in 60μL RIPA lysis buffer (SIGMA, St Louis, MO) and protease inhibitor and incubated on ice for 
1hr. The lysis buffer was then centrifuged @ 10,000rpm for 10min at 4°C. The supernatant was 
then transferred to a new eppendorf tube and protein quantity measured via BCA protein assay 
(Thermo Scientific, Rockford, IL) with a 96 well plate and the Spectra Max M2 machine 
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(Molecular Devices, Sunnyvale, CA) using Soft Max Pro 2 software. Calculations for protein 
concentration were then made and 20μg of each sample was added to the appropriate volume 
of laemmli sample buffer and 2-mercaptoethanol (Bio-Rad, Hercules, CA) in a 475μL: 25μL ratio. 
After the mix was prepared, each sample was boiled @ 95°C for 5 minutes and 
electrophoretically resolved using 4-15% Tris/Glycine Mini-Protean TGX gel (Bio-Rad, Hercules, 
CA), then electroblotted onto polyvinylidene fluoride membranes (Millipore, Billerica, MA). 
Membranes were blocked in Starting block TBS blocking buffer (Thermo Scientific, Rockford, IL) 
for 1 hour and incubated overnight with 1:300 diluted primary antibody CEMP1 (T-15) (Santa 
Cruz Biotechnology). Secondary antibody was donkey anti-goat IgG-HRP conjugated to 
horseradish peroxidase (Santa Cruz Biotechnology), diluted to 1:2000 and incubated for 2 hours 
and then washing with TBS buffer and Tween 20 (BioExpress, Baltimore, MD). Immunoblot 
bands were visualized by enhanced chemiluminescence using the West-Pico ECL detection 
system (Pierce Biotechnology).  
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Chapter 3- Results 
PDL Isolation 
            PDL cells grew out of the PDL tissues isolated from the freshly extracted teeth. On 
average PDL cells grew from 57% of the 30 teeth collected. Cell growth from the tissues was 
seen anywhere from five days to two weeks from the initial PDL extraction. Marked cell growth 
was noticed from extracted premolars compared to third molars. No PDL cells grew from the 
carious or periodontally involved teeth. Teeth not immediately placed in media, resulted in a 
very low success of PDL cell growth. The plated tissues were kept and their media replaced 
regularly for up to a month. If no growth was seen at that point, they were discarded. Under 
light microscopy at 10X magnification, the cells were spindle or stellate shaped with a single 
large nucleus, resembling the morphology of a typical fibroblast. Pictures were taken of the first 
cells to grow from the PDL tissue (Fig. 1). When confluent, the cells were arranged in parallel 
arrays. Once cells in the second to third passage looked approximately 90 percent confluent 
they were used for magnetic bead isolation. 
 
Magnetic Bead Isolation 
            A magnetic bead isolation technique was used to isolate STRO-1+ PDL cells. 
Approximately 1.4% of the total cells initially subjected to the magnetic bead isolation released 
by the DNase were considered to be STRO-1 positive (Aminlari, Kapila et al., 2011). A smaller 
percentage of cells that were still bound to the Dynabeads were considered STRO-1 positive 
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and grown as well. Figure 2 shows a phase contrast microscopic image of STRO-1 positive cells 
with bound beads creating a colony-forming unit. The cell is multipolar, stellate shaped, and 
able to form colonies. Figure 3 shows a phase contrast microscopic image of bead isolated aged 
STRO-1 positive cells (P 11) displaying discernible changes in morphology. 
 
Immunofluorescence 
            In addition to magnetic bead isolation, immunocytochemistry was performed to further 
show that the magnetic bead isolated cells were positive for the STRO-1 and CEMP1 marker. 
STRO-1 expression was identified with green fluorescence (FITC). CEMP1 expression was 
identified with red fluorescence (Texas Red). The isolated cell population expressed the cell 
surface molecule STRO-1 in both young (P 3) and aged (P 11) cells. A portion of the parental PDL 
cells stained green, while almost none of the Supernatant or STRO-1 negative cells stained 
green. Also note, the merged images w/ FITC and Texas Red as a yellowish green color 
indicating cells positive for STRO-1 are simultaneously positive for CEMP1 displaying expression 
for both markers in both young and aged cells (Fig. 4-6). 
 
Western blot 
            To further demonstrate on a protein level PDL cells were isolated for the CEMP1 
marker, western blotting for CEMP1 was performed on parental PDL, STRO-1/CEMP1 double 
positive, STRO-1 double negative, and cementoblastoma cells. CEMP1 expression was evident 
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in parental PDL, STRO-1 positive and cementoblastoma (TCN) cells but not in STRO-1 negative 
cells. Bands are observed for CEMP1 at approximately 50 KDa as expected. All cell strain 
samples were normalized to Beta-actin with bands visible at approximately 42 KDa (Fig. 7). 
 
Osteogenic/Cementogenic Induction 
            Parental PDL cells, STRO-1/CEMP1 positive cells, STRO-1 negative cells, 
Cementoblastoma cells, and human mesenchymal stem cells were osteogenically induced in a 
time course fashion for mRNA analysis and for Alizarin red S staining. The cell strains were 
induced in both a ‘young’ (P 3-4) and ‘aged’ (P 11-13) state and at 0 hr, 6hr, 24hr, 72hr and 1 
week, RNA isolation was performed. By one week, hMSC, STRO-1/CEMP1 positive, and STRO-1 
negative cells revealed a pyramidal shape with multiple spicule-like nodules. This was 
progressive starting on average, at around 72hr for both young and aged cells with more 
nodule formation in an aged state. Young parental PDL and STRO-1/CEMP1 positive cells 
appeared to be more confluent yet both as well as the STRO-1 negative cells kept their bipolar 
shapes with parallel clusters. This was not the case for the TCN cells in both regards; as time 
progressed, these cells morphologically evolved into cuboidal-shaped clusters of cells. The PDL, 
STRO-1/CEMP1 positive and TCN cells had nodules while the STRO-1 negative cells had few to 
none. Cell morphology for the aged cells on the other hand was quite different for parental 
PDL, STRO-1/CEMP1 positive, and TCN cells as their shapes became more flattened with 
increased volume. They were also less confluent and not arranged in parallel clusters. The 
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STRO-1 negative cells however maintained their confluency and parallel array. It was also noted 
that nodule formation appeared to increase in aged PDL, STRO-1/CEMP1 positive, STRO-1 
negative and TCN cells. Images for young and aged parental PDL, STRO-1/CEMP1 positive, 
STRO-1 negative and cementoblastoma cells are shown in figures 8 and 9 respectively. 
            Osteogenic induction of parental PDL, STRO-1/CEMP1 positive, STRO-1 negative and 
cementoblastoma cells for quantitative analysis was also performed after two weeks; after two 
weeks of induction, cells were then stained with Alizarin Red S stain and evaluated. Visually, the 
osteoinduced young parental PDL, STRO-1/CEMP1 positive, and TCN cells had more appreciable 
nodule staining than the STRO-1 negative group however, once the cells aged, a visibly 
recognizable change occurred with nodule formation staining for the STRO-1 negative cells (Fig. 
17 and 18). Quantification with cetylpyridinium chloride and spectrophotometry showed 
certain similar results. All the osteoinduced cell strains young or aged had significantly more 
nodule staining than their control counterpart (P< 0.05). The induced aged STRO-1 negative 
cells had significantly more nodule staining than the induced young counterparts and the 
induced young PDL cells had significantly more staining than the induced aged counterparts (P< 
0.05). There was no significant difference in Alizarin red S staining between the young and aged 
STRO-1/CEMP1 positive and TCN cells (P> 0.05). 
 
 
 
[34] 
 
Messenger RNA Expression (Baseline Study and Time Course Study) 
            A baseline expression of CEMP1, osteopontin, and collagen I in ‘young’ and ‘aged’ 
parental PDL, STRO-1/CEMP1 positive, STRO-1 negative, and cementoblastoma (TCN) cells was 
evaluated and normalized to the housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). Comparing young versus aged cells, the results revealed a 208-fold 
upregulation of CEMP1 expression in aged STRO-1/CEMP1 positive cells (P< 0.05). Also revealed 
was a downregulation of CEMP1 expression in aged parental PDL, STRO-1 negative, and TCN 
cells which was not considered significant (P> 0.05).  Relative expression for osteopontin 
showed a 10.2- and 12.9-fold upregulation in both aged PDL and STRO-1 positive cells 
respectively (P< 0.05), while a down regulation occurred  in both TCN and STRO-1 negative cells 
which was not significant (P> 0.05). Relative expression for collagen 1 showed a 2.1-, 3.0- and 
2.0-fold upregulation in aged PDL, STRO-1 positive and STRO-1 negative cells respectively (P< 
0.05). A downregulation of expression for collagen 1 in aged TCN cells was noted as well 
however this was not considered significant (P> 0.05), (Fig. 10-12).  
            A time course experiment with and without osteogenic induction evaluating mRNA 
expression of CEMP1, osteopontin, and collagen 1 in ‘aged’ and ‘young’ parental PDL, STRO-
1/CEMP1 positive, STRO-1 negative, cementoblastoma, and human mesenchymal stem cells 
(hMSCs) was also performed and normalized to GAPDH. Absorbance ratio and concentration of 
mRNA for young and aged cells are listed in tables 1 and 2. Calculations for fold 
increase/decrease and P values are listed in tables 4-6. The results revealed a progressive 
increase in CEMP1 expression for aged PDL cells with a  3 fold upregulation for induced and 
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untreated cells at 24 hours, a 7-fold upregulation for induced cells at 72 hours, and a peak 12-
fold upregulation at 1 week for untreated (UT) aged cells (P < 0.05). An increase in CEMP1 
expression was also noted for aged STRO-1/CEMP1 positive cells at 72 hours of osteogenic 
induction with a 2-fold and 5-fold upregulation at one week for the aged induced and untreated 
cells respectively (P< 0.05). CEMP1 expression in the aged cementoblastoma (TCN) cells 
revealed a shift from 0 - 24 hours of induction, to 24hr through one week. A 4-fold and 2-fold 
downregulation of CEMP1 expression for aged TCN cells at 6 hours and 24 hours was noted 
respectively (P< 0.05), yet at 72 hours and one week, a 2-fold  upregulation of CEMP1 
expression occurred for untreated and induced (UT, Tx) cells respectively (P< 0.05). CEMP1 
expression for STRO-1 negative young and aged cells was less overall compared to all the other 
cell strains. A significant 3-fold downregulation for CEMP1 was noted for aged untreated STRO-
1 negative cells at 24 hours (UT, P< 0.05) and a 19-fold and 2.9-fold downregulation at one 
week for both Tx and UT groups occurred respectively (P < 0.05). CEMP1 expression for aged 
hMSC cells revealed a noticeable downregulation for untreated cells at 72 hours and induced 
cells at one week however this was not significant (P< 0.05). No significant differences were 
noted between young and aged cells from 0hr through 24 hours. To summarize, CEMP1 
expression was significantly upregulated for aged treated and untreated parental PDL and 
STRO-1/CEMP1 positive cells. A bi-phasic shift however occurred in CEMP1 upregulation for 
TCN cells from young to aged cells beginning at 6 hours through 24 hours (young cells), then 
shifting from 72 hours to one week (aged cells), (Fig. 14). 
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            Collagen 1 expression for parental PDL cells showed a progressive increase for aged cells 
beginning at 24 hours with a 7-fold upregulation at one week for untreated cells (P< 0.05), and 
a 2-fold upregulation for induced cells (P< 0.05). For one week induced young and aged PDL cell 
groups, a dramatic decrease in relative expression for collagen 1 occurred overall. STRO-
1/CEMP1 positive aged cells revealed a progressive significant upregulation of collagen 1 
expression through time for aged cells treated and untreated, beginning at 6 hours and peaking 
at one week (UT) with an 18-fold increase in expression (P< 0.05). Upregulation of collagen 1 at 
72 hours for untreated aged STRO-1/CEMP1 positive cells however was not considered 
significant (P> 0.05). Collagen 1 expression for aged induced TCN cells was significantly 
upregulated 4-fold and 5-fold for induced cells at 72 hours and one week respectively (P< 0.05) 
and significantly downregulated 3.5-fold for untreated (UT) control cells at one week as well (P< 
0.05). In STRO-1 negative cells, collagen 1 expression showed a significant downregulation for 
aged cells throughout the time course with a peak 3-fold downregulation at 72 hours (UT, P< 
0.05) and then a 4-fold upregulation for treated aged cells at one week (Tx, P< 0.05). Collagen 1 
expression for aged hMSC cells showed a significant upregulation beginning at 24 hours (2-fold 
increase) and continuing throughout the time course peaking with a 10-fold increase at one 
week for untreated control cells (P< 0.05) and a 45-fold increase in expression at one week (P< 
0.05) for induced cells. To summarize, a significant upregulation of collagen 1 occurred for aged 
treated and untreated parental PDL, STRO-1/CEMP1 positive, and hMSC cells beginning as early 
as 6 hours (STRO-1/CEMP1 positive cells) and spanning throughout the one week time course 
study (Fig. 15). 
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            Osteopontin expression for aged parental PDL cells showed a 2-fold and 3-fold 
upregulation in expression at 72 hours and one week respectively for induced cells (Tx, P< 
0.05). At all other time points, there was no significant difference between groups. STRO-
1/CEMP1 positive aged cells showed a progressive significant increase in osteopontin 
expression from 24 hours to one week with a peak 55-fold upregulation at one week for 
induced cells (Tx, P< 0.05) as well as a 62-fold upregulation at one week for untreated control 
cells (UT, P< 0.015). Relative expression of osteopontin in STRO-1/CEMP1 positive cells was 
greatest for induced cells at one week. TCN cells showed the highest relative expression for 
aged untreated cells at 72 hours and at which time a significant 3.9-fold downregulation 
occurred for aged induced cells (Tx, P< 0.05). Relative expression of osteopontin for STRO-1 
negative cells increased for aged cells through 72 hours at which time a 4-fold increase in 
expression occurred for induced cells however, this was not significant (P> 0.05). At one week, a 
significant 6.8-fold downregulation had occurred for aged, induced cells (Tx, P< 0.05). 
Osteopontin relative expression for hMSC cells remained higher for young cells from 24 hours 
to one week with no significant differences between young and aged cells prior to that point in 
time and peaking at one week for young cells as well as revealing a significant 6-fold and 8-fold 
downregulation for control and induced aged cells (P< 0.05) respectively. To summarize, 
osteopontin expression was upregulated in aged induced STRO-1 negative cells and significantly 
upregulated in aged induced parental PDL and STRO-1/CEMP1 positive cells, between 72 hours 
and one week (Fig. 16). 
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Chapter 4-Discussion 
            Despite the many methods proposed for periodontal regeneration ie; guided tissue 
regeneration, guided bone regeneration, the use of membranes, bone morphogenetic proteins, 
and enamel matrix proteins, none have targeted cementogenesis specifically and sought to 
reliably initiate the regeneration of cementum and subsequent attachment of the 
periodontium. Part of this is due to the lack of knowledge about the process of cementogenesis 
and about the potent capability of cementoblasts with particular interest to their precursors or 
origin. Unpublished work by Aminlari et al. 2011, has confirmed with the use of cementum 
protein 1 (CEMP1) as a cementum marker, that STRO-1/CEMP1 double positive cells from the 
PDL appear to be possible precursors to cementoblasts. Their study went on to demonstrate 
successful expression of both markers, STRO-1 and CEMP1 on these double positive cells via 
immunofluorescence as well as compositional data suggesting that the mineralized-like tissue 
formed by these osteogenically induced double positive cells displayed a Ca/P ratio of 1.89 
which is very close to cellular cementum at 1.97 (Arzate et al. 2000). In light of this nonetheless, 
mRNA expression levels for CEMP1 however were highest in the osteogenically induced 
parental PDL group, not the STRO-1/CEMP1 double positive group as expected. It was 
theorized, that these “younger” early passage parental PDL cells possessed all the growth 
factors and features necessary to initiate cementogenesis as opposed to the late passage, 
serially diluted and aged STRO-1/CEMP1 double positive cells. Perhaps a younger, earlier 
passage STRO-1/CEMP1 double positive PDL cell osteogenically induced and evaluated sooner 
than a 14 day observation period, would not only reveal the temporal expression of cementum 
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protein 1, but possibly higher levels as well.  Aminlari was able to conclude that STRO-1/CEMP1 
double positive cells from the PDL exhibit characteristics consistent with precursors to 
cementoblasts.  
            In this study, we investigated the effect of cellular aging on the temporal expression of 
CEMP1. This was organized as an initial baseline and then subsequent time course experiment 
including four different cell strains in the baseline study and an additional cell strain or a total of 
five different cell strains in the time course study. The cell strains included: parental periodontal 
ligament cells, cementoblastoma cells (TCN), STRO-1/CEMP1 double positive cells (CEMP1 
positive), STRO-1 double negative cells and human mesenchymal stem cells (hMSC). We 
successfully isolated periodontal ligament cells from the PDL tissue of freshly extracted teeth as 
demonstrated in previous studies (Xu et al., 2009; Aminlari et al., 2011). We then showed that it 
is possible to isolate STRO-1 positive cells through magnetic bead isolation using a mouse 
antibody against human STRO-1. Several studies suggest that STRO-1 is an early marker of 
undifferentiated stem cells, and the expression may decrease over time with each passage 
(Zhou et al., ’08; Itaya et al., ’09; Yamato et al., ’10). Immunofluorescence performed on both 
passage 3 as well as passage 11 Dynabead isolated (STRO-1 positive) cells using the STRO-1 
antibody and FITC however, showed significant staining even in the aged cells (Fig. 4 and 5 
respectively). Through immunofluorescence, we also demonstrated successful expression of 
both STRO-1 and CEMP1 markers on aged STRO-1/CEMP1 double positive cells using the STRO-
1 antibody and FITC as well as the CEMP1 antibody and Texas Red by merging the two images 
(Fig. 5).  
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            The culturing, maintenance and aging of any cell strain can be challenging. Multiple 
variables coupled with operator error may wreak havoc with the simple plating of a specific cell 
strain or the ongoing maintenance of a particular time course experiment prior to its fruition. 
Hayflick defines and clarifies the terms “cell line” and “cell strain” and would argue the term 
“cell line” to be inapplicable to the type of cells described in this study. The term “cell line” is 
confined to only those cells grown in vitro for extended periods of time (years), which as a 
result, presumes potential “immortality” when serially cultivated in vitro. The cells described in 
this study are therefore assumed to lack this characteristic of potential immortality and exclude 
them from being referred to as “cell lines” rather, a more appropriate term such as “cell 
strains.” A cell strain therefore, is a population of cells derived from animal tissue, subcultivated 
more than once in vitro, and lacking the property of indefinite serial passage while preserving 
the chromosomal karyotype characterizing the tissue of origin (Hayflick et al., 1961). Once 
decidedly operating in full force with a particular cell strain, the method of ‘aging’ this cell strain 
may be achieved in several ways. A cell may age through multiple passages or through a 
substantial amount of time that it takes to achieve confluency, not to mention the stresses 
induced to the cell during the process.   
            Several investigators have performed in vitro cellular aging via sequential subcultivation 
techniques according to Hayflick (Hayflick, 1977) and/or variations thereof. For example, Goseki 
et al transferred PDL cells from freshly extracted human premolars onto 35mm culture dishes 
and when the cells had reached confluence, they were designated “passage 1.” The cells were 
then detached w/ 0.05% trypsin and then subcultured in 75cm2 culture flasks until confluent 
because the number of PDL cells at confluence in this flask  they calculated to be approximately 
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1 x 106 cells. When the PDL cells reached confluency at one-week intervals, they were 
subcultivated in a 4:1 split ratio (2.5 x 105 cells/flask) so that two population doublings per 
subcultivation would result. After the 15th passage, the growth rate of the cells decreased 
markedly with the doubling time requiring 10 or more days to reach confluence and therefore a 
2:1 split ratio was then performed in order to both effectively and efficiently age the cells in a 
more timely fashion. Goseki and his group considered cells at an early passage (less than 30% of 
the number of population doublings, or passage 6 to 7) to be ‘young’ and at late passage (more 
than 75% of the number of population doublings, or passage 17 to 20) to be ‘old.’ Goseki 
considers human PDL cells, which are fibroblasts with limited proliferation, suitable as an in 
vitro aging model for studying the biochemical basis of cellular aging. When considering 
morphological criterion in young versus old or aged cell cultures, PDL cells displayed increased 
cell volume with advancing cell passages, and the aging cells grew much more slowly. Increase 
in cell size with aging as well as reduced replicative properties are considered to be typical 
parameters of cellular aging (Goseki, Shimizu et al., 1996). In our study which involved a time 
course model, we isolated PDL cells in the very same manner however chose to subcultivate on 
10cm culture plates until confluent or approximately 2-2.5 x 106 cells. Each passage consisted of 
a 4:1 ratio split onto 10cm culture plates until passage 11-13 at which time a 9:1 split ratio was 
performed onto nine 6cm plates to allow for five different time points (0hr, 6h, 24h, 72h and 
1wk) of RNA isolation evaluating induced and non-induced cells. Unlike Goseki’s experiment 
with PDL cells only, we also included two additional cell strains in our study; one of which 
(cementoblastoma or “TCN” cell) was terminally differentiated and therefore challenging to age 
in a timely fashion as this cell strain not only grew slowly, but by passage 8, became increasingly 
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difficult to maintain. It is believed that the cultured cementum tumor cells (TCN cells) in this 
study would be useful for at least three reasons: First, they could be used to obtain sufficient 
quantities of biologically active cementum components as this has been difficult so far due to 
the paucity of cementum in human teeth and labor intensive dissection procedures necessary. 
Second, the cells could be used to study the biosynthesis and processing of CAP and other 
cementum proteins. Third, early cementogenesis is believed to involve deposition of 
extracellular matrix produced by Hertwig’s epithelial root sheath (HERS) cells on dentin, 
disruption of the HERS, migration and attachment of ectomesenchymal cells from dental follicle 
on to the matrix, their differentiation into cementoblasts and laying down of cementum (Arzate 
et al., 1992).  
            A baseline investigation of CEMP1 expression via reverse transcription real-time 
polymerase chain reaction comparing young versus aged PDL cells provided a reference for 
intended results that were far from expected. Significant upregulation of CEMP1 in aged STRO-
1/CEMP1 positive cells was quite opposite of what was anticipated. In addition, significant 
upregulation for Collagen 1 was also revealed in aged parental PDL, STRO-1/CEMP1 positive and 
STRO-1 negative cells as well. Finally, results of a significant increase for osteopontin expression 
in aged parental PDL and STRO-1/CEMP1 positive cells prompted a more in-depth time course 
study to: A) confirm or at least coincide with the baseline results, and B) establish at certain 
time points when induced and control cells (young and aged) peak with a specific gene 
expression. Results of the time course experiment not only coincided with the baseline study, 
but also exceeded certain expectations. CEMP1 expression was indeed upregulated in aged 
parental PDL, STRO-1/CEMP1 positive and TCN cells but not in human mesenchymal stem cells 
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and it stands to reason as hMSC cells are not differentiated or ‘programmed’ well enough to 
allow for such expression. CEMP1 relative expression in young and aged STRO-1 negative (and 
theoretically CEMP1 negative) cells was considerably lower throughout the time course as 
expected and significantly downregulated in aged cells after one week of treatment with 
osteogenic media. Attempting to induce these cells toward a mineral producing phenotype 
without the CEMP1 gene or little to no CEMP1 expression was not effective; they displayed a 
significant downregulation in aged cells (19 fold), but also, little to no mineral nodule formation 
in young cells.  On the other hand, CEMP1 expression in young, as well as aged PDL, STRO-
1/CEMP1 positive, and TCN cells revealed nodule formation in the young osteogenically 
induced PDL, STRO-1/CEMP1 positive and TCN cells and increased mineral formation in the 
same aged cells (Fig. 7 and 8). Results of a study by Goseki et al showed a decrease in collagen 
expression of PDL cells with cellular aging (Goseki et al., 1996). Their assays for collagen 
secretion were performed using Sirius Red stain and quantified with spectrophotometry at 
540nm. This in fact, was not the case with our study and our results using RT-qPCR were quite 
different. Relative expression for collagen generally speaking, was upregulated for every aged 
cell strain except the STRO-1 negative cells. The upregulation of collagen occurred as early as 6 
hours (STRO-1/CEMP1 positive cells) and continued throughout the one week time course 
experiment. The authors of Goseki’s article comment on the decreased expression of collagen 
in PDL cells with respect to aging perhaps correlating clinically in a decreased regenerative 
capacity of the PDL cell itself and adjacent tissues. This decreased regenerative capacity 
however is overshadowed by the microenvironment with which these cells reside enduring 
constant trauma and insult. Examination in vitro without the threat of microbiologic 
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destruction, allows the investigator to admire the potential of these cells in an otherwise 
healthy environment as they age. Perhaps the STRO-1 negative cells which are theoretically 
CEMP1 negative because they express minimal to no CEMP1, and also express no upregulation 
of collagen in aged cells, require CEMP1 as a signaling agent or vehicle not only for mineral 
production, but regeneration and repair as well. We see the same influential shift for TCN cells 
as they continue to age through the time course experiment. Increased collagen 1 expression 
with the aged TCN cells is observed as time progresses, possibly due to the upregulation of 
CEMP1 occurring at the same time at the same shift point between 24 and 72 hours. It is at this 
time point and thereafter that we notice a significant upregulation of collagen 1 for induced 
aged cells (4 fold at 72hr and 5 fold at one week).              
            It might be suggested that Collagen 1 and CEMP1 are tied together sharing a common 
pathway with one requiring the other, and as the STRO-1/CEMP1 positive cell ages, this 
pathway is either initiated or better yet, upregulated. Perhaps for the STRO-1 negative cell, this 
pathway no longer functions as the cell ages; due to possibly a manifestation of the Collagen 1 
and CEMP1 expression no longer being tied together. Aminlari showed that when isolating 
STRO-1 positive PDL cells through magnetic bead isolation, only approximately 1.4% of the total 
cells along with a smaller percentage bound to the Dynabeads, were considered STRO-1 
positive and therefore a far greater population of STRO-1 negative cells exist (Aminlari et al., 
2011). Theoretically, a parental PDL cell population will have STRO-1 positive and STRO-1 
negative cells but as you age the PDL cells, a predominant cell strain will rise and this might be 
the STRO-1 negative cell. This stands to reason because if a STRO-1/CEMP1 positive cell 
population dominates, cementum deposition would be in excess producing routine pathologic 
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cementoblastomas; therefore a ‘negative feedback’ type of regulation must prevail. This would 
allow for cementum deposition with age, but not to the point of pathologic deposition. Also of 
interest to note, the untreated control aged human mesenchymal stem cells at one week 
revealed a 10 fold upregulation of collagen however, inducing the same aged cells by one week 
also revealed a 45 fold increase in collagen secretion. They also show a progressive 
upregulation of CEMP1 (aged vs young) throughout the time course to nearly a 2 fold increase 
by one week as well which draws attention once again to both CEMP1 and Collagen 1 being tied 
together in a common pathway. The hMSC cells, which are less differentiated than a PDL or 
cementoblastoma cell, show tremendous potential to differentiate into collagen secreting and 
mineral producing cells especially in the aged state; perhaps in a regenerative or repair 
capacity. This is indeed revealed after one week of induction with osteogenic media.      
            Osteopontin (OPN) is a molecule associated with early stages of mineralization. Its 
expression by cementum tumor cells (TCN cells) suggests that this molecule could be associated 
with the initial process of mineralization observed in these particular cells. The synthesis of this 
molecule may be regarded as the expression of a cell with an osteoblast-like phenotype and 
confirms its role as one of the molecules regulating the process of cementogenesis (Arzate et 
al., 1998). An upregulation of OPN is demonstrated for aged PDL, STRO-1/CEMP1 positive and 
STRO-1 negative cells however at one week a shift occurs in the ability to express OPN for 
STRO-1 negative cells with osteogenic media compared with STRO-1/CEMP1 positive cells. It is 
important to bear in mind that OPN is an early maker (osteogenic marker) in mineral 
deposition, not a marker present in early or young cells. We expected to see more expression of 
OPN for TCN cells with treatment as the time course progressed and this was not the case. 
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Untreated young and aged cells up to 72 hours revealed a progressive increase in OPN 
expression and then began to decrease thereafter. The cementoblastoma cells did in fact 
respond but at different times and to differential treatment. Perhaps a ‘generic’ type of 
osteogenic treatment as was used, may actually suppress OPN in these cells especially as they 
age. This might be necessary again as a possible type of negative feedback or rather, these 
terminally differentiated cells simply prefer laying down cementum rather than a bone-like 
mineralized material and the osteogenic media was quite possibly inhibiting the process. Lee et 
al evaluated the effects of aging on human dental pulp cells (HDPCs) with regard to 
dentinogenesis and observed a decrease in OPN expression with aging. To better understand 
the mechanism of the aging process, stress-induced premature senescence (SIPS) was 
performed by treating the HDP cells with H2O2. Odontogenic and osteogenic functions impaired 
by senescence were assayed via several experiments including Western blotting, reverse 
transcriptase polymerase chain reaction and Alizarin Red S staining. Results of oxidative stress-
mediated premature senescence with simple replicative senescence appeared to be similar 
manifesting a decrease of OPN expression (Lee et al., 2013). Environmental stresses can 
markedly differ from the pulp to the periodontium however, with one influencing the other as 
well. Inflammation, oxidative stress along with replicative senescence provided an environment 
in vitro that produced such results for Lee and his group; an environment that was not created 
in our study. To summarize for OPN expression, the STRO-1/CEMP1 positive cells were very 
responsive to mineralization treatment while the cementoblastoma cells were counter-
responsive to mineralization treatment and our data supports the findings of Arzate et al with 
regard to OPN upregulation in the presence of CEMP1 as a potential inducer.  
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            The Arzate group not only showed CEMP1 regulates mineral deposition as demonstrated 
with anti-cementoblastoma protein antibodies thereby decreasing OPN and BSP levels, but they 
also showed using immunolocalization that this cementoblastoma protein was expressed 
specifically in the precementum of acellular and cellular cementum (Arzate et al., 1998, 2006). 
The concept of CEMP1 regulating mineral deposition is therefore not new, nor is the concept of 
increased cementum deposition with aging. Kuttler studied the microscopic basis of the 
anatomy of the dental apex using 402 extracted teeth from patients ranging in age with two 
groups: 18 - 25 and 55 – death. They concluded that the foramen of the root deviates more and 
more from the apical center with an increase of age caused by a thickening of the apical 
cementum. Also the diameter of the foramen increased with age due to the apposition of new 
layers of cementum (Kuttler, 1955). Determinations of cementum thickness on 233 single-
rooted teeth with healthy supporting tissues showed a straight-line relationship between age 
and cementum thickness. The thickness of cementum was approximately tripled between the 
ages of 11 and 76 years. This occurred more in the apical region and less around the 
cementoenamel junction (Zander et al., 1958). Stein et al. also examined the microscopic 
structure of the root apex to ascertain what changes, if any, occur over time. They studied 111 
extracted teeth both vital and non-vital from 47 patients ranging from 26-77 years old. It was 
noted that as age increased, the width of the cementum appeared to increase as well. They 
indicate that Nitzan et al. ascribed to the increase in the width of cementum to the aging 
process, not to physiologic changes (Stein et al., 1990). Our data supports this finding via RT-
qPCR, time course osteoinduction and Alizarin Red staining which reveal an upregulation of not 
only CEMP1 expression, but OPN and Collagen expression as well. This was seen in parental 
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PDL, STRO-1/CEMP1 positive, and cementoblastoma cells, but not consistently or at all in hMSC, 
and STRO-1 negative cells. It was interesting to observe via spectrophotometry, significantly 
more nodule formation with Alizarin Red S staining for aged STRO-1 negative cells compared to 
young STRO-1 negative cells however not similarly with aged STRO-1/CEMP1 positive, PDL, and 
TCN cells despite the visibly increased staining. This may be due in part, to the differences in 
osteoinduction time of one week for the time course vs two weeks of induction for the Alizarin 
Red S staining. Confining the aged cells to a 6 well plate for two weeks could have dramatically 
altered the capabilities of these particular cell strains and perhaps warrants further 
investigation. 
            To conclude, we have demonstrated successful aging of parental PDL, STRO-1/CEMP1 
positive, STRO-1 negative, human mesenchymal stem and cementoblastoma cells, which were 
able to produce mineralized-like tissue in an ‘aged’ state. CEMP1 expression was significantly 
upregulated during the aging process for several cell strains including STRO-1/CEMP1 positive 
cells and these cells continued to exhibit characteristics consistent with precursors to 
cementoblasts. This will aid in advancing our knowledge of the mechanisms involved with 
cementogenesis, cellular aging and ultimately periodontal regeneration as well as helping 
improve current methodologies for treating patients with periodontitis and attachment loss. 
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Tables and Figures 
 
 
Figure 1: Phase contrast image of PDL tissue (Bottom) giving rise to PDL cells (top). 
 
 
 
[50] 
 
 
 
 
Figure 2: Phase contrast image of post-bead isolation of PDL cells using human STRO-1 
antibody. Note the STRO-1 positive cells attached to the gold Dynabeads. 
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Figure 3: Phase contrast image of aged (P 11) STRO-1 positive bead-isolated cells. Note the 
changes in morphology from spindle shapes to more flattened shapes with increased cell 
volume. 
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Figure 4: Immunofluorescent images staining for STRO-1, CEMP1, and the nucleus with P-3 
cells. The blue color represents DAPI staining of the nucleus. The green color represents 
staining of the STRO-1 marker with FITC. The Red color represents staining of the CEMP1 
marker with Texas Red.  a,d,g show FITC staining of STRO-1 on STRO-1-, STRO-1+, and TCN cells 
respectively. b,e,h show Texas Red staining of CEMP1 marker on STRO-1-, STRO-1+, and TCN 
cells respectively. c,f,I demonstrate merging of STRO-1 and CEMP1 staining where both markers 
are present. 
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Figure 5: Merged microscopic image of aged P-11 STRO-1 positive bead isolated PDL cells 
stained for STRO-1 with FITC, CEMP1 with Texas Red, and the nucleus with DAPI. 
 
 
 
 
[54] 
 
 
Figure 6: STRO-1 negative P-11 (Supernatant or non-bead isolated PDL cells) cells stained for 
both STRO-1 and CEMP1. Both stains were negative. Nuclei are stained blue with DAPI. 
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Figure 7: Protein expression by Western blot. Parental PDL (PDL), STRO-1 positive (S+), STRO-1 
negative (S-), and cementoblastoma (TCN) cells assayed for CEMP1 expression and normalized 
to Beta-actin. Note bands for parental PDL, STRO-1 positive and cementoblastoma cells and no 
band visible for STRO-1 negative cells.  
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Figure 8: Phase contrast images revealing young (P 3-4) cells in both control and osteogenic 
media. Note images e,f,h depicting small nodule formation. a,e parental PDL cell. b,f STRO-1 (+) 
Dynabead isolated cells. c,g STRO-1 (-) cells. d,h cementoblastoma cells. 
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Figure 9: Phase contrast images revealing aged (P 11-13) cells in both control and osteogenic 
media. Note images e, f, and h depicting small nodule formation. a,e parental PDL cell. b,f 
STRO-1 (+) Dynabead isolated cells. c,g STRO-1 (-) cells. d,h cementoblastoma cells. 
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Figure 10: Baseline trial of real time PCR showing Cementum Protein 1 (CEMP1) mRNA relative        
expression comparing young (P 3-4) versus aged (P 11-13) cells in four different cell strains 
normalized to GAPDH. Note Significant upregulation of CEMP1 expression in “aged” STRO-1 
positive cells compared to others (P< 0.05). Also note downregulation of CEMP1 expression in 
“aged” PDL, TCN and STRO-1 negative cells which was not considered significant (P>0.05).  
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Figure 11: Baseline trial of real time PCR showing Collagen 1 (Col 1) mRNA relative        
expression comparing young (P 3-4) versus aged (P 11-13) cells in four different cell strains 
normalized to GAPDH. Note significant upregulation of Col 1 expression in “aged” PDL, STRO-1 
positive and STRO-1 negative cells compared to others (P< 0.05).  
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Figure 12: Baseline trial of real time PCR showing Osteopontin (OPN) mRNA relative        
expression comparing young (P 3-4) versus aged (P 11-13) cells in four different cell strains 
normalized to GAPDH. Note significant upregulation of OPN expression in “aged” PDL and 
STRO-1 positive cells compared to others (P< 0.05).  
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Figure 13: Time course experiment image of nine 6cm plates displaying the cell strain (STRO-1 
negative), age of cell strain (P4), different time points (0hr-1wk) as well as osteogenic induction 
(Tx) and untreated control (UT) cells. 
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Table 1: 260/280 absorbance ratio and 
concentrations of young cell (P 3-4) mRNA 
samples measured in a Beckman DU-640 
spectrophotometer. mRNA was isolated at five 
different time points from five different cell types. 
Cells were either untreated (UT) or osteogenically 
induced (Tx).  
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Table 2: 260/280 absorbance ratio and 
concentrations of aged cell (P 11-13) mRNA 
samples measured in a Beckman DU-640 
spectrophotometer. mRNA was isolated at five 
different time points from five different cell types. 
Cells were either untreated (UT) or osteogenically 
induced (Tx). 
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Table 3: TaqMan® gene expression assay ID and probe sequences for GAPDH, Collagen 1, 
Osteopontin (OPN), and Cementum Protein 1 (CEMP1). 
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Fig. 14: Time course trial of real time PCR 
showing CEMP1 expression for young and aged 
PDL, STRO-1/CEMP1 positive, TCN, STRO-1 
negative and hMSC cells. Relative expression 
(Y-axis) evaluated from 0hr through one week 
(X-axis) comparing control cells (UT) and 
osteogenically induced cells (Tx). * indicates 
significant upregulation or downregulation of 
aged cells P< 0.05. 
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Fig. 15: Time course trial of real time PCR 
showing Collagen 1 expression for young and 
aged PDL, STRO-1/CEMP1 positive, TCN, 
STRO-1 negative and hMSC cells. Relative 
expression (Y-axis) evaluated from 0hr 
through one week (X-axis) comparing control 
cells (UT) and osteogenically induced cells 
(Tx). ). * indicates significant upregulation or 
downregulation of aged cells P< 0.05. 
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Fig. 16: Time course trial of real time PCR 
showing Osteopontin expression for young and 
aged PDL, STRO-1/CEMP1 positive, TCN, STRO-1 
negative and hMSC cells. Relative expression (Y-
axis) evaluated from 0hr through one week (X-
axis) comparing control cells (UT) and 
osteogenically induced cells (Tx). ). * indicates 
significant upregulation or downregulation of 
aged cells P< 0.05. 
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Table 4: Fold increase/decrease and P value 
calculations for CEMP1 time course experiment 
comparing aged vs young cells. Fold value > 2 and P 
value < 0.001 considered significant. Values calibrated 
and standardized to 0hr UT. Note (-) value indicates 
decrease or downregulation. 
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Table 5: Fold increase/decrease and P value 
calculations for Collagen 1 time course experiment 
comparing aged vs young cells. Fold value > 2 and P 
value < 0.001 considered significant. Values calibrated 
and standardized to 0hr UT. Note (-) value indicates 
decrease or downregulation. 
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Table 6: Fold increase/decrease and P value calculations 
for OPN time course experiment comparing aged vs 
young cells. Fold value > 2 and P value < 0.001 
considered significant. Values calibrated and 
standardized to 0hr UT. Note (-) value indicates 
decrease or downregulation. 
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Fig. 17: Alizarin red S staining images of four 6-well plates seeded with young (P 3-4) parental 
PDL (a), STRO-1/CEMP1 positive (b), TCN (c), and STRO-1 negative (d) cells in triplicate. Top row 
of each plate represents osteoinduced (Tx) cells showing Alizarin red S staining of the PDL, 
STRO-1/CEMP1 positive and TCN nodules while bottom row of each plate represents cells in 
control media with no nodule formation. Note little to no staining of STRO-1 negative plate.   
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Fig. 18:  Alizarin red S staining images of four 6-well plates seeded with aged (P 11-13) parental 
PDL (a), STRO-1/CEMP1 positive (b), TCN (c), and STRO-1 negative (d) cells in triplicate. Top row 
of each plate represents osteoinduced (Tx) cells showing Alizarin red S staining of the PDL, 
STRO-1/CEMP1 positive TCN, and STRO-1 negative nodules while bottom row of each plate 
represents cells in control media with no nodule formation. Note significantly more staining of 
the aged STRO-1 negative plate compared to young STRO-1 plate in figure 17.   
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